Psychedelic medicine: a re-emerging therapeutic paradigm
Kenneth W. Tupper, Evan Wood, Richard Yensen, Matthew W. Johnson
Canadian Medical Association Journal September 8, 2015 DOI: 10.1503/cmaj.141124 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Addiction Anxiety |
| Keywords | Posttraumatic stress Depression economics Psychotherapist Clinical psychology |
| Citations | 189 |
| Key findings | Psychedelic substances are being reinvestigated in clinical research for treating addiction, depression, anxiety, and PTSD. |
Abstract
In clinical research settings around the world, renewed investigations are taking place on the use of psychedelic substances for treating illnesses such as addiction, depression, anxiety and posttraumatic stress disorder (PTSD). Since the termination of a period of research from the 1950s to the